A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
Clinical trial NCT04739761 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04739761
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-22
- Primary completion
- 2024-02-08
- Enrollment
- 506
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.